WEBINAR
Procalcitonin (PCT)-based antimicrobial stewardship
28 Sep, Thursday
18:00 - 19:00 (GMT+8)
Antimicrobial stewardship program promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms. Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process. Studies have shown that the infection marker, procalcitonin (PCT), is helpful for reducing antibiotic exposure without compromising patient safety.
In this webinar, A/Prof Andrea Kwa will discuss the clinical utility of PCT on antibiotic stewardship in the management of sepsis and lower respiratory tract infections (LRTI) including pneumonia and share her experience on PCT-guided antibiotic stewardship program in her hospital. Dr Asok Kurup will be moderating this webinar and sharing his experience in the management of sepsis from the perspective of an Infectious Disease Physician.
Who should attend:
- Infectious Disease Specialist: As the webinar delves into the role of PCT in the management of Sepsis, Pneumonia, and LRTIs, infectious disease physicians would greatly benefit from the insights and experiences shared by A/Prof Andrea Kwa and Dr Asok Kurup
- Hospital Pharmacists: With a focus on the appropriate use of antimicrobials, hospital pharmacists can apply the knowledge gained to enhance their antibiotic management protocols and promote better therapeutic decision-making
- Intensive Care Professionals: The management of Sepsis and LRTI are critical areas in the emergency department and ICU. ICU physicians, nurses, and clinical staff who are actively involved in patient care can benefit from learning about the latest techniques and strategies in antibiotic stewardship
- Lab Specialists: Understand how the biomarkers are used in the clinical settings of sepsis, bacterial infection, LRTI, and antibiotic stewardship.
Faculty
Moderator
Dr Asok Kurup, MBBS, MRCP, MMed
Infectious Disease Physician,
Infectious Diseases Care Pte Ltd,
Mount Elizabeth,
Singapore
ModeratorDr Asok Kurup, MBBS, MRCP, MMed
Infectious Disease Physician, |
Dr Asok Kurup is an infectious disease physician practising at the Mount Elizabeth Hospital, Singapore. His clinical expertise encompasses managing diverse infections ranging in complexity from outpatient to inpatient care. He is the current chair of the Chapter of Infectious Diseases Physicians, Academy of Medicine, Singapore where he continues to contribute to the development of the specialty in the country. He also serves as a member, panel of infectious diseases experts for COVID-19 vaccines and therapeutics, Health Science Authority (2020 to current), and is also a member of Workgroup for COVID-19 Therapeutics, National Centre for Infectious Diseases (2020 to current). He is the Chair of the Antibiotic Stewardship Committee, IHH Healthcare Singapore and continues to chair the Infection Control Committee of Mount Elizabeth Hospital (2012-2016, 2020 to current). He remains a representative to the National Antimicrobial Resistance Control Committee (NARCC) (2021 to current).
Speaker
A/Prof Andrea Kwa, PharmD
Associate Professor,
Duke-NUS Medical School,
Assistant Director (Research) Department of Pharmacy,
Singapore
SpeakerA/Prof Andrea Kwa, PharmD
Associate Professor, |
A/Prof Andrea Kwa graduated with a degree in Pharmacy from the National University of Singapore in 1996 and received her Doctor of Pharmacy Degree from the Albany College of Pharmacy and Health Sciences in New York in 2006. Dr Kwa is currently a Pharmacy Clinician Scientist and Assistant Director, Pharmacy (Research), at the Singapore General Hospital. She is also a faculty member of the Emerging Infectious Diseases program at Duke-NUS Medical School. She specializes in critical care medicine, infectious diseases and antimicrobial resistance research. She helms a laboratory studying antimicrobial pharmacodynamics/pharmacokinetics and resistance. She also performs health services research involving antimicrobial stewardships, risk factors and outcomes of resistant infections. Dr Kwa has authored more than 60 publications and is a reviewer for many scientific journals.
Agenda
| Time | Topic | Speakers |
|---|---|---|
| 18:00-18:10 | Introduction | Dr Asok Kurup |
| 18:10 - 18:45 | Procalcitonin (PCT)-based antimicrobial stewardship | A/Prof Andrea Kwa |
| 18:45 - 19:00 | Q&A and closing | Moderated by Dr Asok Kurup |
Live Webinar Date & Time
 |
Date:15th June 2023 at 13:00-14:30 (GMT+8) |
 |
|